SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · Real-Time Price · USD
3.190
+0.020 (0.63%)
Nov 21, 2024, 1:23 PM EST - Market open

Company Description

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space.

The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities.

Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific.

SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.

SOPHiA GENETICS SA
SOPHiA GENETICS logo
Country Switzerland
Founded 2011
IPO Date Jul 23, 2021
Industry Health Information Services
Sector Healthcare
Employees 430
CEO Jurgi Camblong

Contact Details

Address:
La PiEce 12
Rolle, 1180
Switzerland
Phone 41 21 694 10 60
Website sophiagenetics.com

Stock Details

Ticker Symbol SOPH
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $18.00
CIK Code 0001840706
CUSIP Number H82027105
ISIN Number CH1125843347
SIC Code 7374

Key Executives

Name Position
Dr. Jurgi Camblong M.B.A., Ph.D. Co-Founder, Chief Executive Officer and Director

Latest SEC Filings

Date Type Title
Nov 19, 2024 144 Filing
Nov 19, 2024 144 Filing
Nov 19, 2024 144 Filing
Nov 19, 2024 144 Filing
Nov 19, 2024 144 Filing
Nov 19, 2024 144 Filing
Nov 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 5, 2024 6-K Report of foreign issuer
Nov 5, 2024 6-K Report of foreign issuer
Oct 22, 2024 144 Filing